Mathematical modelling of the most effective goal of cholesterol-lowering treatment in primary prevention
Objective To compare quantitatively different recommended goals for cholesterol-lowering treatment in the primary prevention of atherosclerotic cardiovascular disease (ASCVD).Design Outcomes at pretreatment low-density lipoprotein (LDL) cholesterol concentrations from 2 to 5 mmol/L and 10-year ASCVD...
Saved in:
| Main Authors: | Handrean Soran, Safwaan Adam, Paul Durrington, Zohaib Iqbal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-05-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/5/e050266.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How Does HDL Participate in Atherogenesis? Antioxidant Activity Versus Role in Reverse Cholesterol Transport
by: Paul N. Durrington, et al.
Published: (2025-04-01) -
Achievement of LDL-Cholesterol Goals in Patients Receiving LLT in Primary Care: TERESA-AP Study
by: Sergio Cinza-Sanjurjo, et al.
Published: (2024-01-01) -
Heart rate reduction as a therapeutic goal: focus on primary prevention
by: Yu. A. Orlova, et al.
Published: (2012-02-01) -
Are weight loss and metabolic outcomes of bariatric surgery influenced by candidate glucocorticoid receptor gene polymorphisms? A prospective study
by: Zohaib Iqbal, et al.
Published: (2024-12-01) -
Intestinal alkaline phosphatase is a receptor for cholesterol-lowering pentapeptide IIAEK and regulates cholesterol homeostasis in mice
by: Asahi Takeuchi, et al.
Published: (2025-07-01)